Ophira Ginsburg

As an adjunct scientist at Women's College Research Institute and an assistant professor at U of T, Ginsburg traveled to rural Bangladesh to improve the health conditions of women. While there, her research team educated women on breast health and established the countries first breast center.^[3][4] As a result of her global health efforts, Ginsburg was awarded one of 15 Rising Stars in Global Health Awards from Grand Challenges Canada.^[3] The following year, she also named a 2013 YWCA Women of Distinction Awards for her innovative work to improve the lives of women and girls.^[5]

In 2015, Ginsburg was appointed a Medical Officer by the World Health Organization to help create guidelines and programs to provide earlier diagnosis and treatment of cancers affecting women.^[6] She was also recognized as one of the Top 300 Women Leaders in Global Health by the Graduate Institute of International and Development Studies.^[7] At the same time, Ginsburg published research which indicated that South Asian women, excluding those of Chinese descent, were more likely to be diagnosed at a higher stage of breast cancer than the general population.^[8] Two years later, she was named the Director of NYU Langone Health's Perlmutter Cancer Center's High Risk Program for patients with hereditary syndromes that increase cancer risk.^[9] In 2020, Ginsburg was appointed an inaugural Elsa Atkin Distinguished Fellow at the George Institute for Global Health.^[10] During the COVID-19 pandemic, Ginsburg co-authored a paper in Nature Cancer titled "Eliminating cervical cancer in the COVID-19 era."^[11] In 2022, Ginsburg won the American Society of Clinical Oncology's Humanitarian award.^[12] Ophira Ginsburg was also recognized as one of the 100 Influential Women in Oncology by OncoDaily.^[13]

Scholia has a profile for Ophira Ginsburg (Q89490068).

• Ophira Ginsburg publications indexed by Google Scholar